Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Handbook of Experimental Pharmacology
|
May 24, 2019
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Michele Biagioli, Adriana Carino
Liver Research
|
February 17, 2025
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
Michele Biagioli, Stefano Fiorucci
Pharmacological Research
|
July 19, 2018
Future trends in the treatment of non-alcoholic steatohepatitis
Stefano Fiorucci, Michele Biagioli, Eleonora Distrutti
Digestive Diseases and Sciences
|
February 8, 2021
Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis
Stefano Fiorucci, Eleonora Distrutti, Michele Biagioli
Digestive Diseases and Sciences
|
April 4, 2018
Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases
Stefano Fiorucci, Michele Biagioli, Eleonora Distrutti
Liver Research (Beijing, China)
|
April 10, 2025
Bile acids and their receptors in hepatic immunity
Stefano Fiorucci, Silvia Marchianò, Eleonora Distrutti, et al.
Frontiers in Immunology
|
August 29, 2018
Bile Acids Activated Receptors Regulate Innate Immunity
Stefano Fiorucci, Michele Biagioli, Angela Zampella, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders
Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti, et al.
Expert Opinion on Investigational Drugs
|
June 20, 2020
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
Stefano Fiorucci, Michele Biagioli, Valentina Sepe, et al.
Molecular and Cellular Endocrinology
|
April 26, 2022
Immunomodulatory functions of FXR
Stefano Fiorucci, Angela Zampella, Patrizia Ricci, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Handbook of Experimental Pharmacology
|
May 24, 2019
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Michele Biagioli, Adriana Carino
Liver Research
|
February 17, 2025
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
Michele Biagioli, Stefano Fiorucci
Pharmacological Research
|
July 19, 2018
Future trends in the treatment of non-alcoholic steatohepatitis
Stefano Fiorucci, Michele Biagioli, Eleonora Distrutti
Digestive Diseases and Sciences
|
February 8, 2021
Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis
Stefano Fiorucci, Eleonora Distrutti, Michele Biagioli
Digestive Diseases and Sciences
|
April 4, 2018
Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases
Stefano Fiorucci, Michele Biagioli, Eleonora Distrutti
Liver Research (Beijing, China)
|
April 10, 2025
Bile acids and their receptors in hepatic immunity
Stefano Fiorucci, Silvia Marchianò, Eleonora Distrutti, et al.
Frontiers in Immunology
|
August 29, 2018
Bile Acids Activated Receptors Regulate Innate Immunity
Stefano Fiorucci, Michele Biagioli, Angela Zampella, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders
Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti, et al.
Expert Opinion on Investigational Drugs
|
June 20, 2020
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
Stefano Fiorucci, Michele Biagioli, Valentina Sepe, et al.
Molecular and Cellular Endocrinology
|
April 26, 2022
Immunomodulatory functions of FXR
Stefano Fiorucci, Angela Zampella, Patrizia Ricci, et al.
Page
of 9